… The evidence of a dysregulated host immune response has prompted the investigation of
immunomodulatory therapies for abrogating lung injury in COVID-19. There are >2500 studies …

… This review focuses on the immunopathogenesis and treatment of COVID-19 with …
immunopathology can be linked to the Th17 pathway. In summary, COVID-19 immunopathology can …

… evidence related to different aspects of COVID-19 immunology, including innate and adaptive
… Understanding immunology of COVID-19 is important in developing effective therapies as …

… novel Coronavirus disease 2019 (COVID-19). For this reason, many researchers have tried
to implement therapies to mitigate the cytokine storm in the treatment of COVID-19 patients, …

… COVID-19, continuous extensive investigations are in progress to determine the effective
therapeutic agents … Studies converge on drug discovery against emerging COVID-19 outbreaks …

… and may be a stage of COVID-19 progression. A premium is … the cytokine storm syndrome
in COVID-19. The review discusses … therapy of the cytokine storm syndrome in COVID-19. …

… The severe outcome in COVID-19 and immunopathology of SARS-CoV-2 can be … anti-COVID-19
drugs, the evidence for their clinical effectiveness is insufficient in COVID-19. The FDA …

… Elucidating the immunopathological outcomes due to COVID-19 could provide potential …
care, therapeutic approaches to COVID-19 treatment involve the use of antiviral agents that …

… COVID-19 immunology research and discuss definitive findings and remaining questions
regarding our understanding of COVID-19 … a need for new therapeutics and hence a need for a …

… immunopathogenesis, of cytokine storm in COVID-19 patients has the potential to guide
future strategies to improve early diagnosis and implement therapeutic … for COVID-19 patients, …